Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
1733:TPE
Apex Biotechnology Corp
28,55 NT$
-0,52%
(-0,15) 1D
30 apr, 13:30:37 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 1733...
Açın
28,50 NT$
High
28,95 NT$
Low
28,50 NT$
Mkt. cap
2,85 mlrd
Avg. vol.
146,25K
Volume
78,09K
P/E ratio
17,62
52-wk high
38,70 NT$
52-wk low
27,00 NT$
EPS
1,62 NT$
Shares outstanding
99,69 mln
No. of employees
641
News stories
From sources across the web
About Apex Biotechnology Corp
CEO-
Employees641
Founded1997
Headquarters-
SectorMedical device
Websiteapexbio.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in TWD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
558,75 mln
509,95 mln
437,21 mln
438,99 mln
Cost of goods sold
396,09 mln
373,05 mln
330,39 mln
306,63 mln
Cost of revenue
396,09 mln
373,05 mln
330,39 mln
306,63 mln
Research and development expenses
40,44 mln
36,96 mln
35,94 mln
36,02 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
57,68 mln
56,59 mln
57,27 mln
62,79 mln
Operating expense
106,46 mln
93,64 mln
98,80 mln
99,12 mln
Total operating expenses
502,55 mln
466,69 mln
429,19 mln
405,75 mln
Operating income
56,20 mln
43,26 mln
8,02 mln
33,24 mln
Other non operating income
412,00K
360,00K
775,00K
894,00K
EBT including unusual items
80,36 mln
22,16 mln
29,21 mln
58,17 mln
EBT excluding unusual items
84,32 mln
-938,00K
34,02 mln
57,52 mln
Income tax expense
18,38 mln
-6,60 mln
7,12 mln
7,97 mln
Effective tax rate
22,86%
-29,80%
24,37%
13,70%
Other operating expenses
-
-
-
-
Net income
62,03 mln
28,65 mln
22,14 mln
50,08 mln
Net profit margin
11,10%
5,62%
5,06%
11,41%
Earnings per share
-
-
-
-
Interest and investment income
88,00K
5,69 mln
139,00K
1,49 mln
Interest expense
-880,00K
-851,00K
-835,00K
-822,00K
Net interest expenses
-792,00K
4,84 mln
-696,00K
665,00K
Depreciation and amortization charges
-
-
-
-
EBITDA
69,29 mln
55,93 mln
20,24 mln
45,47 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer